Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1049 of 3330
Next
>>
>
26201 to 26225 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
184A1	NM	Basal	FR180204	ERK1/2	MAPK	0.00128	uM	12509.166	1.0195	1.0303	1.2847
184A1	NM	Basal	FR180204	ERK1/2	MAPK	0.0064	uM	12509.166	1.0063	1.0098	1.2847
184A1	NM	Basal	FR180204	ERK1/2	MAPK	0.032	uM	12509.166	1.1006	1.1550	1.2847
184A1	NM	Basal	FR180204	ERK1/2	MAPK	0.16	uM	12509.166	1.0300	1.0466	1.2847
184A1	NM	Basal	FR180204	ERK1/2	MAPK	0.8	uM	12509.166	0.9195	0.8735	1.2847
184A1	NM	Basal	FR180204	ERK1/2	MAPK	4	uM	12509.166	1.0643	1.0993	1.2847
184A1	NM	Basal	FR180204	ERK1/2	MAPK	20	uM	12509.166	0.8978	0.8390	1.2847
184A1	NM	Basal	FR180204	ERK1/2	MAPK	100	uM	12509.166	0.5704	0.2919	1.2847
184B5	NM	Basal	FR180204	ERK1/2	MAPK	0.000256	uM	12566.166	0.9966	0.9943	1.2010
184B5	NM	Basal	FR180204	ERK1/2	MAPK	0.00128	uM	12566.166	1.0327	1.0543	1.2010
184B5	NM	Basal	FR180204	ERK1/2	MAPK	0.0064	uM	12566.166	0.9851	0.9751	1.2010
184B5	NM	Basal	FR180204	ERK1/2	MAPK	0.032	uM	12566.166	1.0602	1.0997	1.2010
184B5	NM	Basal	FR180204	ERK1/2	MAPK	0.16	uM	12566.166	1.0019	1.0032	1.2010
184B5	NM	Basal	FR180204	ERK1/2	MAPK	0.8	uM	12566.166	0.9644	0.9406	1.2010
184B5	NM	Basal	FR180204	ERK1/2	MAPK	4	uM	12566.166	0.9017	0.8349	1.2010
184B5	NM	Basal	FR180204	ERK1/2	MAPK	20	uM	12566.166	0.6393	0.3780	1.2010
184B5	NM	Basal	FR180204	ERK1/2	MAPK	100	uM	12566.166	0.5439	0.2046	1.2010
600MPE	HR+	Luminal	FR180204	ERK1/2	MAPK	0.000256	uM	12224.161	0.9563	0.8786	0.7139
600MPE	HR+	Luminal	FR180204	ERK1/2	MAPK	0.00128	uM	12224.161	0.9979	0.9942	0.7139
600MPE	HR+	Luminal	FR180204	ERK1/2	MAPK	0.0064	uM	12224.161	0.9699	0.9162	0.7139
600MPE	HR+	Luminal	FR180204	ERK1/2	MAPK	0.032	uM	12224.161	0.9596	0.8878	0.7139
600MPE	HR+	Luminal	FR180204	ERK1/2	MAPK	0.16	uM	12224.161	1.0201	1.0565	0.7139
600MPE	HR+	Luminal	FR180204	ERK1/2	MAPK	0.8	uM	12224.161	0.9318	0.8115	0.7139
600MPE	HR+	Luminal	FR180204	ERK1/2	MAPK	4	uM	12224.161	1.0075	1.0211	0.7139
600MPE	HR+	Luminal	FR180204	ERK1/2	MAPK	20	uM	12224.161	0.8849	0.6851	0.7139

|<
<<
Previous
Page 1049 of 3330
Next
>>
>
26201 to 26225 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)